Smooth Drug Development, next generation e-CRO in Europe and Asia

Smooth Drug Development offers a full range of clinical trial, drug registration and post-marketing services, including consulting, development of registration strategy, conduct of clinical studies and pharmacovigilance in Europe and Asia. We cover wide geography: -Russia -Belarus -Kazakhstan -Latvia -Lithuania -Estonia -Serbia -Slovakia -Hungary -Germany -Spain -Turkiye -India -Pakistan -China Our company implemented the principle of one stop service when all activities from planning to product registration are performed consistently under the control of a team of professionals. According to the requirements of ISO 9001:2015, in case of outsourcing of vendors we manage their activities as our ones and are...

Animal studies,clinical trials phase i-iv,bioequivalence studies,biosimilars,drug dossier preparation,drug registration,regulatory support/cta,pharmacovigilance,bioanalytics,clinical monitoring,cro in russia and cis,post-marketing surveillance,clinical trials in russia,clinical trials in ukraine,clinical trials in belarus,clinical trials in cis,clinical trials in cee,cro in russia,cro in ukraine,cro in belarus,cro in cis,cro in europe,cro in eastern europe,clinical trials in europe,clinical trials in eastern europe,cro in hungary,cro in serbia,cro in croatia,cro in baltic states,clinical trials in baltic states,data management,e-pro,electronic diaries,data management in clinical trials,clinical trials in oncology,cro,clinical trial services,phase i-iv clinical trials,early phase clinical trials,first in human clinical trials,epro solutions,electronic clinical outcome assessments,electronic clinical data management,clinical trial data management system, patient reported outcomes,ediary, eclinical outcomes assessments, electronic clinical trial data capture,etmf,epro,eisf,and cro in asia

Smooth drug development, next generation e-cro in europe and asia operates in the Biotechnology research industry.

Smooth drug development, next generation e-cro in europe and asia's revenue is 11m - 100m

Smooth drug development, next generation e-cro in europe and asia has 11 - 50 employees.